FDA panel wants limits on anemia drugs (AP)
Date : 2008 03 13 Category : Health
AP - Federal advisers said anemia drugs sold by Amgen Inc. and Johnson & Johnson should be sharply restricted to a segment of cancer patients a recommendation that could cost the companies millions.